Markets:

Overview

News

Currencies

International

Treasuries

Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)

6.355 -0.275 (-4.15%)

Streaming Delayed Price Updated: 2:46 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xeris Biopharma Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

60 Biggest Movers From Yesterday ↗

August 24, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...

Via Benzinga

Why Xeris Pharmaceuticals Shares Traded Higher Today ↗

August 23, 2021

Xeris Pharmaceuticals Inc (NASDAQ: XERS) is trading significantly higher Monday after the company announced U.S. Food and Drug Administration approval of its...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 23, 2021

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a...

Via Benzinga

Why Is Xeris Pharmaceuticals (XERS) Stock Shining On Monday ↗

August 23, 2021

The

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

August 23, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...

Via Benzinga

Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke® Kit for the Treatment of Severe Hypoglycemia

August 23, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Xeris Pharmaceuticals Strengthens Its Patent Estate

August 19, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 17, 2021

Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

Xeris Pharmaceuticals Achieves Unprecedented Levels of Payor Coverage for Gvoke®

August 13, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

54 Stocks Moving In Thursday's Mid-Day Session ↗

August 12, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 12, 2021

Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million....

Via Benzinga

30 Stocks Moving in Thursday's Pre-Market Session ↗

August 12, 2021

Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ...

Via Benzinga

Xeris To Test Hypothyroidism Candidate In Healthy Subjects, Stock Moves Higher ↗

August 12, 2021

The FDA has signed off Xeris Pharmaceuticals Inc's (NASDAQ: XERS) Investigational New Drug Application (IND) for its XeriSol levothyroxine (XP-8121) for...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 11, 2021

Gainers Hims & Hers Health (NYSE:HIMS)...

Via Benzinga

Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol™ Levothyroxine (XP-8121) for the Treatment of Hypothyroidism

August 11, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

August 05, 2021

During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

99 Biggest Movers From Yesterday ↗

August 06, 2021

Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 05, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....

Via Benzinga

Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights

August 05, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

July 29, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Xeris Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

July 29, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For August 5, 2021 ↗

August 05, 2021

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Xeris Pharmaceuticals Announces Executive Changes as Part of Its Strategy to Position the Company for Long-Term Commercial Success

July 28, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

Xeris Pharma, Tetris Ink Commercialization Pact For Ogluo In Europe ↗

July 19, 2021

Xeris Pharmaceuticals Inc (NASDAQ: XERS) has entered into an exclusive agreement with Tetris Pharma Limited to commercialize Ogluo in the European...

Via Benzinga

Xeris Pharmaceuticals Enters Into an Exclusive License and Supply Agreement with Tetris Pharma Limited to Commercialize Ogluo® in Europe

July 19, 2021

From Xeris Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.